SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Sharck Soup
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREENLAW4-7 who wrote (8898)2/5/2001 8:08:09 AM
From: Sharck   of 37746
 
Thanks Green,
QLTI is on the leading edge with photodynamic therapy, an emerging field of medicine utilizing light-activated drugs in the treatment of disease. The objective of Visudyne therapy is to slow or potentially arrest the progression of wet age-related macular degeneration (AMD). They have a near monopoly in this area and getting more approval and partners should be extremely positive. I bought the calls and looking for 100% return, or is that 1000% LOL....
S
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News